Craig S.Miller, Sidney A.Houff, JasonHopper, Robert J.Danaher, Julie A.Gurwell, YushunLin, NubiaVega, Joseph R.Berger. (2012) Disease-modifying drugs for multiple sclerosis and JC virus expression. Journal of NeuroVirology 18 , 411-415 /...
Currently, six disease‐modifying drugs (DMD) for multiple sclerosis are available in Japan: subcutaneous interferon‐β‐1b, intramuscular interferon‐β‐1a, glatiramer acetate, natalizumab, fingolimod and dimethyl fumarate. These drugs have different clinical and adverse effects. Therefore, it is ...
Multiple Sclerosis Medically reviewedby Drugs.com. Last updated on Feb 9, 2025. Care notes Ambulatory Discharge Español MS is a disease that leads to inflammation and damage to parts of your central nervous system (CNS). The CNS includes your brain, spinal cord, and nerves. MS causes your...
Stimulated by the successful introduction of interferon-β as treatment for relapsing-remitting multiple sclerosis (MS) and based on an improved knowledge of the immunopathology of MS, a vast array of treatment options is currently under investigation for disease course modification. These are targeting...
Treating aging patients with immunomodulatory drugs further increases the risk of infections. A review of infections in patients with multiple sclerosis (MS) finds an inherent risk from the related disabilities, and the possibility of increased risk from disease-modifying therapies (DMT) with ...
Medications prescribed for multiple sclerosis are of two primary types: Disease-modifying drugs include: Immunomodulators Immunosuppressants Sphingosine 1-phosphate (S1P) receptor modulators Symptom management drugs include: Corticosteroids Dopamineagonists ...
Disease-modifying drugs: Mechanisms of action and the future of multiple sclerosis therapeuticsdisease modifying drugsmultiple sclerosis patientsSupported by an educational grant from Teva Neuroscience. Expert Medical Education contributed to the editorial refinement of this article and to the production of ...
Multiple Sclerosis Disease modifying treatment National guideline United Arab Emirates Middle East Gulf UAE 1. Introduction The United Arab Emirates (UAE) is home to about 10 million people, of which one million are Emirati citizens. UAE is considered a country with medium prevalence for Multiple ...
Learn about your options for treating multiple sclerosis (MS), including different types of disease-modifying drugs, various therapies, and lifestyle changes.
(2003) Dise- ase-modifying therapies for multiple sclerosis. Curr Treat Opt in Neurol, 5(1):35-54.John R. Corboy, Douglas S. Goodin, Elliot M. Frohman. (2003) Disease-modifying therapies for multiple sclerosis. Current Treatment Options in Neurology 5 , 35-54 /...